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Objectives: The results of treatment for subclavian vein effort thrombosis were assessed in a series of competitive athletes.
Methods: A retrospective review was conducted of high-performance athletes who underwent multidisciplinary manage-
ment for venous thoracic outlet syndrome in a specialized referral center. The overall time required to return to athletic
activity was assessed with respect to the timing and methods of diagnosis, initial treatment, operative management, and
postoperative care.
Results: Between January 1997 and January 2007, 32 competitive athletes (29 male and 3 female) were treated for venous
thoracic outlet syndrome, of which 31% were in high school, 47% were in college, and 22% were professional. The median
age was 20.3 years (range, 16-26 years). Venous duplex ultrasound examination in 21 patients had a diagnostic sensitivity
of 71%, and the mean interval between symptoms and definitive venographic diagnosis was 20.2 5.6 days (range, 1-120
days). Catheter-directed subclavian vein thrombolysis was performed in 26 (81%), with balloon angioplasty in 12 and
stent placement in one. Paraclavicular thoracic outlet decompression was performed with circumferential external
venolysis alone (56%) or direct axillary-subclavian vein reconstruction (44%), using saphenous vein panel graft bypass
(n 8), reversed saphenous vein graft bypass (n 3), and saphenous vein patch angioplasty (n 3). In 19 patients (59%),
simultaneous creation of a temporary (12 weeks) adjunctive radiocephalic arteriovenous fistula was done. The mean
hospital stay was 5.2  0.4 days (range, 2-11 days). Seven patients required secondary procedures. Anticoagulation was
maintained for 12 weeks. All 32 patients resumed unrestricted use of the upper extremity, with a median interval of 3.5
months between operation and the return to participation in competitive athletics (range, 2-10 months). The overall
duration of management from symptoms to full athletic activity was significantly correlated with the time interval from
venographic diagnosis to operation (r 0.820, P< .001) and was longer in patients with persistent symptoms (P< .05)
or rethrombosis before referral (P < .01).
Conclusions: Successful outcomes were achieved for the management of effort thrombosis in a series of 32 competitive
athletes using a multidisciplinary approach based on (1) early diagnostic venography, thrombolysis, and tertiary referral;
(2) paraclavicular thoracic outlet decompression with external venolysis and frequent use of subclavian vein reconstruc-
tion; and (3) temporary postoperative anticoagulation, with or without an adjunctive arteriovenous fistula. Optimal
outcomes for venous thoracic outlet syndrome depend on early recognition by treating physicians and prompt referral for
comprehensive surgical management. (J Vasc Surg 2008;47:809-21.)Effort thrombosis of the subclavian vein (Paget-
Schroetter syndrome) is a relatively uncommon condition
affecting young, active, otherwise healthy individuals.1-3 It
is caused by compression and repetitive injury of the sub-
clavian vein at the level of the first rib and is therefore
considered a form of thoracic outlet syndrome (TOS).
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doi:10.1016/j.jvs.2007.10.057Venous TOS is distinct from other forms of TOS with
respect to pathophysiology, clinical presentation, and func-
tional consequences for the patient; thus, optimal manage-
ment of effort thrombosis requires different considerations
and approaches from those applicable to either neurogenic
or arterial TOS.4-6
Contemporary management of effort thrombosis varies
widely. Although conservative management with anticoag-
ulation and arm elevation was frequently used in the past,
this approach rarely results in symptom-free use of the arm
and imposes limitations that appear unacceptable to most
patients.7-12 The general consensus now is that better
outcomes are achieved by early use of catheter-directed
thrombolytic therapy.13,14 It is also apparent that patients
remain at significant risk for recurrent thrombosis after
thrombolysis and anticoagulation alone, that balloon an-
gioplasty does not provide durable treatment for residual
subclavian vein stenosis, and that placement of stents
should be avoided.11,15-17 Surgical decompression of the
thoracic outlet has therefore become favored in most situ-
809
for surgical management.
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selection, timing of intervention, or specific techniques for
operative treatment.
During the past decade, our group has embraced a
comprehensive multidisciplinary approach to the manage-
ment of all forms of TOS, including a standardized proto-
col for the treatment of effort thrombosis. To evaluate this
approach in a challenging patient population, we reviewed
the outcomes of treatment for venous TOS in a series of
highly competitive athletes with particular reference to
their return to sports-related activities. The success of this
approach suggests that similar strategies are applicable to
most individuals with venous TOS.
METHODS
Patient population. Patients with venous TOS were
identified through a clinical database of all patients treated
for TOS on the vascular surgery service at Washington
University School of Medicine and Barnes-Jewish Hospital
(St Louis, Mo). Competitive athletes at the time of presen-
tation were identified for review, as defined by active par-
ticipation in organized individual or team sports, or both,
at the high school, collegiate, or professional levels. Recre-
ational athletes and those involved solely in physical condi-
tioning or weight-lifting programs were excluded, as were
competitive athletes with arterial or neurogenic forms of
TOS. Detailed information for each patient was summa-
rized from office notes, hospital charts, and records from
treating physicians, physical therapists, and athletic trainers.
The study was approved by the Washington University
School of Medicine Institutional Review Board.
Data analysis. The principal clinical outcome assessed
was the overall duration of management as measured by the
time interval between the onset of symptoms and a full
return to athletic activity. This end point was then assessed
in relationship to the timing and methods of diagnosis,
initial treatment, operative management, and postoperative
care. Descriptive group data are presented as the mean 
standard error (SEM) or the median and range of values.
The Pearson correlation test was used to examine asso-
ciations between continuous variables, and comparisons
between subgroups weremade using theMann-WhitneyU
test or analysis of variance with multiple comparisons test-
ing. All statistical tests were performed using InStat 3.0a
software (GraphPad Software Inc, San Diego, Calif), with
values of P  .05 considered significant.
RESULTS
Patient population. Between January 1997 and Jan-
uary 2007, 276 patients underwent surgical treatment for
all forms of TOS, including 100 patients with subclavian
vein effort thrombosis (40% of the total). Thirty-two of the
patients treated for venous TOS, were competitive athletes,
representing one-third of the patients with venous TOS
and 12% of all TOS patients during the period reviewed
(Fig 1, A). This patient population consisted of 29 male
(91%) and three female (9%) athletes, with a median age of
20.3 years at the time of treatment (range 16-26 years;Fig 1. Distribution of patients, diagnosis, and referral. A, Distri-
bution of 276 consecutive patients undergoing operative treat-
ment for thoracic outlet syndrome (TOS) at Washington Univer-
sity from January 1997 to January 2007. The subset of competitive
athletes with venous TOS is indicated. B,Use and results of upper
extremity duplex ultrasound examinations in the initial diagnosis
of suspected effort thrombosis in 32 competitive athletes. C,
Location of initial venographic diagnosis, treatment, and referral
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(47%) were college students, and seven (22%) were full-
time professional athletes.
Clinical presentation, diagnosis, and initial man-
agement. None of the patients in this series had previous
venous thrombosis, central venous catheterization, or
recent trauma. All but one initially presented with spon-
taneous swelling of the arm, cyanotic discoloration, or
recent distention of subcutaneous veins; most patients
also had arm fatigue, heaviness, or pain with use. In the
single patient without arm swelling, the initial symptom
was dizziness and shortness of breath due to bilateral
pulmonary embolism, with subclavian vein thrombosis
found unexpectedly during the search for an embolic
source. The side affected by venous TOS was the domi-
nant right arm in 26 patients (81%), the dominant left
arm in two (6%), and the nondominant left arm in four
(13%; Table I).
An upper extremity venous duplex ultrasound (DUS)
examination was the first step in diagnostic evaluation in 21
patients (66%). Although the results of these studies in 15
patients were positive for subclavian, axillary, or brachial
vein thrombosis, they were considered normal in six pa-
tients for a diagnostic sensitivity of only 71% (Fig 1, B and
Supplemental Fig A, I, on-line only). One patient under-
Table I. Competitive athletes with subclavian vein effort t
Patient Sex Age Principal sport
1 M 16 Football
2 M 18 Baseball
3 M 18 Basketball
4 M 17 Football
5 M 18 Soccer
6 M 17 Tennis
7 F 16 Swimming
8 M 19 Baseball
9 M 16 Baseball/football
10 M 18 Swimming
11 M 22 Basketball
12 F 19 Basketball
13 M 21 Fencing
14 M 21 Swimming
15 M 23 Fencing
16 F 21 Volleyball
17 M 19 Football
18 M 21 Baseball
19 M 21 Basketball
20 M 20 Football
21 M 18 Baseball
22 M 20 Baseball
23 M 24 Basketball
24 M 19 Baseball
25 M 20 Baseball
26 M 26 Baseball
27 M 25 Football
28 M 24 Baseball
29 M 26 Baseball
30 M 26 Baseball
31 M 21 Baseball
32 M 23 Baseballwent gadolinium-enhanced magnetic resonance (MR)venography as the initial diagnostic study, with the clear
demonstration of focal subclavian vein obstruction (Fig 2,
A and B).
The mean interval between the onset of symptoms and
a definitive diagnosis of subclavian vein thrombosis, as
proven by direct contrast venography, was 20.2 5.6 days
(median, 4.5 days; range, 1-120 days; Table II). Initial
management included catheter-directed thrombolysis in
26 patients (81%), with 20 treated before referral (Supple-
mental Fig A, II on-line only). In most patients, this
resulted in improved flow through the subclavian vein, with
demonstration of a focal high-grade stenosis at the level of
the first rib (Fig 2, D-F). Twelve patients treated elsewhere
had subclavian vein balloon angioplasty, including one
patient with placement of a subclavian vein stent. All pa-
tients were maintained on therapeutic anticoagulation with
heparin or warfarin after the initial diagnosis or interven-
tional management.
Six patients (19%) underwent initial venography and
thrombolysis at our institution, with surgical treatment
intended within 3 weeks. An additional 14 patients (44%)
were initially managed elsewhere, with direct referral or
transfer for surgical treatment (Fig 1, C). For these 20
patients, the mean interval from diagnosis to operative
treatment was 20.6  4.3 days (median, 19.5; range, 2-66
bosis
evel of competition Dominant side Affected side
High school R R
High school R R
High school R R
High school R R
High school R R
High school L L
High school R R
High school R R
High school R R
High school R R
College R L
College R R
College R R
College R L
College R L
College R R
College R R
College R R
College R R
College R R
College R R
College L L
College R R
College R R
College R R
Professional R R
Professional R R
Professional R L
Professional R R
Professional R R
Professional R R
Professional R Rhrom
Ldays). In contrast, 12 patients (37%) underwent initial
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Volume 47, Number 4 Melby et al 813Fig 2. Radiographic and operative findings in venous thoracic outlet syndrome. A-C, Gadolinium-enhanced mag-
netic resonance (MR) venogram in a 26-year-old right-handed baseball player demonstrates right subclavian vein
occlusion (arrows) with the arms in (A) neutral and (B) elevated positions that correspond to the lesion subsequently
observed by (C) direct contrast venography. D-F, Contrast venograms in a 26-year-old right-handed baseball pitcher
with (D) a long segment subclavian vein occlusion on the initial study (arrow), (E) improved flow and appearance with
focal subclavian vein stenosis 22 hours after thrombolysis (arrow), and (F) focal subclavian vein occlusion with arm
elevation (arrow).G, In this typical operative specimen of the left first rib excised during paraclavicular thoracic outlet
decompression, the scalene tubercle is indicated (arrow).H, This operative photograph of the left subclavian vein after
circumferential external venolysis shows thick residual scar tissue encasing the proximal subclavian vein and restricting
its diameter even after complete mobilization (arrow). A saphenous vein panel graft bypass was performed from the end
of the normal subclavian vein to the side of the jugular-subclavian vein junction (asterisks), with excision of the
intervening native subclavian vein. I,Operative specimen of the subclavian vein containing an indwelling stent (arrow,
inset), which was excised during paraclavicular decompression and subclavian vein bypass graft reconstruction. J-L,
Drawings show the techniques used for (J) subclavian vein patch angioplasty, (K) excision of the obstructed proximal
segment of the subclavian vein, and (L) surgical reconstruction with interposition bypass using a saphenous vein panel
graft. IJV, Internal jugular vein; SCV, subclavian vein; BCV, brachiocephalic (innominate) vein. M, Initial contrast
venogram in a 20-year-old baseball pitcher presenting with right arm swelling and extensive axillary-subclavian vein
thrombosis. N, Venogram immediately after thrombolysis and balloon angioplasty. O, Repeat venogram after 2
months of anticoagulation, during which the patient had persistent symptoms. The appearance of chronic recurrent
axillary-subclavian vein occlusion was considered inoperable before referral. P, Follow-up postoperative venogram after
thoracic outlet decompression and subclavian vein reconstruction using a saphenous vein panel graft illustrates a widely
patent venous system and absence of collateral flow. The patient experienced prompt relief of arm swelling and returned
Hospitals in the St Louis metropolitan area other than WU/BJH.
dHospitals in regions of the country outside the Midwest.Table II. Diagnosis and initial management
Patient No.
Interval Sx to
Dx, days
Location of initial
management
Thrombolytic
therapy
Balloon
angioplasty
Results/outcome of
initial management
1 3 Other Midwesta   Direct refer/transferb
2 3 Other Midwest   Persist Sx; refer 1 mo
3 60 WU/BJH   Surgery same admission
4 7 Other Midwest   Direct refer/transfer
5 120 Other St Louisc   Rethromb; refer 3 mo
6 3 Other Midwest   Direct refer/transfer
7 100 Other St Louis   Persist Sx; refer 1 mo
8 2 WU/BJH   Surgery 3 weeks
9 3 Other Midwest   Rethromb; refer 4 mo
10 42 WU/BJH   Surgery 3 weeks
11 1 Other Midwest   Direct refer/transfer
12 14 Other Midwest   Persist Sx; refer 7 mo
13 14 Other St Louis   Persist Sx; refer 4 mo
14 42 Other Midwest   Persist Sx; refer 7 mo
15 6 WU/BJH   Surgery same admission
16 5 WU/BJH   Surgery 3 weeks
17 90 Other Midwest   Direct refer/transfer
18 3 Other Midwest   Direct refer/transfer
19 7 Other Midwest   Direct refer/transfer
20 9 Other Midwest   Rethromb; refer 10 mo
21 56 Other distantd   Persist Sx; refer 3 mo
22 2 Other distant  (stent) Rethromb; refer 11 mo
23 28 Other Midwest   Persist Sx; refer 8 mo
24 3 Other distant   Direct refer/transfer
25 4 Other Midwest   Rethromb; refer 2 mo
26 1 Other Midwest   Direct refer/transfer
27 2 Other Midwest   Direct refer/transfer
28 3 Other distant   Direct refer/transfer
29 2 Other distant   Direct refer/transfer
30 3 WU/BJH  – Surgery 3 weeks
31 7 Other distant   Direct refer/transfer
32 2 Other distant   Direct refer/transfer
Dx, Diagnosis (venogram); Rethromb, symptomatic and venographically documented axillary-subclavian vein rethrombosis; Sx, symptoms; WU/BJH,
Washington University/Barnes-Jewish Hospital in St Louis.
aHospitals outside metropolitan St Louis in the states of Ark, Ill, Iowa, Kan, Ky, Mo, Neb, and Tenn.
bDirect referral or transfer to WU/BJH for further management after initial management elsewhere.
cto competitive baseball 4 months later.
ssion
text. T
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lowed by observation or anticoagulation alone, without a
recommendation or referral for surgery. All 12 had persis-
tent symptoms of upper extremity venous congestion with
use of the arm, and five had documented rethrombosis of
the axillary-subclavian vein. The mean interval from diag-
nosis to operative treatment in this late-referral group was
163.3 29.2 days (median, 150; range, 30-330 days; P
.0001 vs early referral, Mann-Whitney).
Surgical treatment. Surgical treatment was offered to
all patients with symptomatic venous TOS or recent effort
thrombosis, regardless of the interval between initial diag-
nosis and referral, previous treatment, or adverse findings
on contrast venography. All patients were managed by the
same vascular surgeon using a consistent operative strategy
throughout the period reviewed (Supplemental Fig A, III
and B, on-line only).6,18 This consisted of paraclavicular
thoracic outlet decompression through a combination of
supraclavicular and medial infraclavicular incisions, includ-
ing complete anterior and middle scalenectomy, brachial
plexus neurolysis, excision of the subclavius muscle tendon,
Table III. Surgical management
Patient Surgical treatmenta
1 External venolysis alone
2 External venolysis alone
3 SCV patch angioplasty (SV)
4 External venolysis alone
5 External venolysis alone  AVF
6 External venolysis alone  AVF
7 External venolysis alone  AVF
8 External venolysis alone  AVF
9 SCV bypass (reversed SV)  AVF
10 SCV bypass (SV panel graft)
11 External venolysis alone
12 External venolysis alone
13 External venolysis alone
14 SCV bypass (reversed SV)
15 SCV bypass (SV panel graft)
16 SCV patch angioplasty (SV)  AVF
17 SCV bypass (reversed SV)
18 SCV Bypass (SV panel graft)  AVF
19 External venolysis alone  AVF
20 External venolysis alone  AVF
21 External venolysis alone  AVF
22 SCV bypass (SV panel graft)  AVF
23 External venolysis alone  AVF
24 SCV bypass (SV panel graft)  AVF
25 SCV bypass (SV panel graft)  AVF
26 External venolysis alone
27 SCV patch angioplasty (SV)
28 External venolysis alone  AVF
29 External venolysis alone  AVF
30 SCV Bypass (SV panel graft)  AVF
31 SCV Bypass (SV panel graft)  AVF
32 External venolysis alone  AVF
Mean  SEM
AVF, Arteriovenous fistula (radiocephalic); SCV, subclavian vein; SV, saphe
aEach patient initially underwent paraclavicular thoracic outlet decompre
circumferential external venolysis of the subclavian vein as described in theand resection of the entire first rib (Fig 2, G). Althoughnone of the patients in this series had a cervical rib, 13
(41%) had aberrant fascial bands within the thoracic outlet,
and 10 (31%) had hypertrophic or anomalous scalene mus-
culature (eg, scalene minimus muscle). Two patients (6%)
had an anomalous phrenic nerve passing anterior to the
subclavian vein. During mobilization of the brachial plexus
nerve roots, 16 patients (50%) were noted to have moder-
ately severe perineural fibrosis.
Circumferential external venolysis was performed in all
patients, extending from the axillary vein to the subclavian-
jugular-innominate vein junction. In most cases the exci-
sion of perivenous scar tissue allowed the underlying sub-
clavian vein to re-expand in caliber, often to a normal
diameter. In 18 of the 32 patients (56%), the axillary and
subclavian veins were also compressible to palpation and
widely patent by intraoperative venography after external
venolysis alone, and no additional venous reconstruction
was performed (Table III). In the remaining 14 patients
(44%), at least one portion of the subclavian vein remained
visibly narrowed, thick-walled to palpation, or venographi-
Hospital stay, days Drain duration, days
8 4
6 5
9 8
3 2
4 10
3 7
4 4
4 6
11 21
6 8
3 5
3 3
2 2
5 7
4 8
4 6
3 6
6 3
5 3
7 13
5 8
11 13
6 10
4 6
6 6
4 4
3 2
5 8
5 7
7 9
6 9
4 6
5.2  0.4 6.8  0.7
ein.
with scalenectomy and complete resection of the first rib, followed by
he specific management of the subclavian vein is indicated.nous vcally obstructed despite circumferential external venolysis
cable.
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proximal subclavian vein (Fig 2, I).
For these patients, direct subclavian vein reconstruc-
tion was performed using autologous saphenous vein. Vein
patch angioplasty was performed for three patients with
mild focal stenosis and minimal irregularity of the luminal
surface upon direct inspection of the opened vein, with the
patch extending from the distal uninvolved subclavian vein
onto the lateral aspect of the internal jugular vein (Fig 2, J).
For 11 patients undergoing subclavian vein bypasses, the
obstructed segment of subclavian vein was excised and an
interposition graft was constructed from the uninvolved
distal subclavian vein (or proximal axillary vein) to the
lateral aspect of the jugular-subclavian junction (Fig 2, K
and L). Although the diameter of the reversed saphenous
vein was an acceptable match for the subclavian vein in
three patients, a saphenous vein panel graft was constructed
in eight patients to provide a more suitable conduit.
The operative procedure in 19 patients (59%) included
creation of a radiocephalic arteriovenous fistula (AVF) at
the wrist,19 often using the mobilized end of the cephalic
Table IV. Secondary procedures, recovery, and follow-up
Patient Procedure (post-op interval, days)
1 Drainage wound hematoma (2)
2 None
3 Drainage hemothorax (2)
4 None
5 None
6 None
7 None
8 Drainage wound hematoma (28)
9 Graft thrombosis/revision (4)
Control lymph leak (17)
10 None
11 None
12 None
13 None
14 None
15 None
16 None
17 None
18 None
19 None
20 None
21 None
22 Graft thrombosis/angioplasty (5)
23 None
24 None
25 Graft thrombosis or angioplasty (10)
26 None
27 None
28 None
29 None
30 None
31 None
32 Wound infection, hemothorax (20)
Mean  SEM
AVF, Arteriovenous (radiocephalic) fistula; F/U, follow-up; N/A, not applivein to perform intraoperative completion venography.The pleural space was opened at the completion of each
operative procedure, the brachial plexus nerve roots were
wrapped with Seprafilm (Genzyme Biosurgery, Cam-
bridge, Mass), and a closed-suction drain was placed into
the supraclavicular/pleural space.
Therapeutic anticoagulation was resumed with intrave-
nous heparin within 3 days of operation, followed by con-
version to oral warfarin. The mean duration of hospitaliza-
tion after surgical treatment was 5.2  0.4 days (range,
2-11 days), and the surgical drain was removed 6.8  0.7
days after the procedure (range, 2-21 days; Table III).
Secondary procedures, recovery, and return to
activity. Seven patients required secondary procedures
during the early postoperative period (Table IV). Subcla-
vian vein bypass graft thrombosis developed in three of
these patients within 2 weeks of the primary operation.
Two underwent reoperation through the supraclavicular
incision with bypass graft thrombectomy, in which one was
treated with intraoperative balloon angioplasty and the
other with bypass graft revision. The third patient was
successfully treated percutaneously by localized mechanical
F closure (weeks)
Return to full activity
(months) F/U, years
3 9.5
3 8.7
6 8.5
8 7.5
ntaneous 2 4.6
tion (8) 10 3.3
tion (9) 3 3.2
tion (14) 5 2.0
ntaneous 3 1.6
3 0.6
3 9.6
3 7.1
6 6.5
4 6.3
3 5.7
ntaneous 8 4.4
3 4.1
tion (12) 4 3.6
ntaneous 3 3.6
tion (11) 3 2.6
tion (11) 4 1.5
tion (13) 4 1.2
ntaneous 3 0.7
tion (11) 5 0.7
tion (12) 4 0.5
2 10.0
3 6.0
tion (10) 3 3.6
tion (15) 5 2.8
tion (14) 6 1.2
tion (12) 8 1.1
tion (14) 8 0.7
 0.5 (n  14) 4.4  0.4 4.2  0.5AV
N/A
N/A
N/A
N/A
Spo
Liga
Liga
Liga
Spo
N/A
N/A
N/A
N/A
N/A
N/A
Spo
N/A
Liga
Spo
Liga
Liga
Liga
Spo
Liga
Liga
N/A
N/A
Liga
Liga
Liga
Liga
Liga
11.9thrombectomy and balloon angioplasty. In each of these
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enhanced by the presence of a widely patent AVF, such that
bypass graft obstruction resulted in the abrupt onset of
marked upper extremity venous congestion, with graft
occlusion considered secondary to postoperative narrowing
of the distal subclavian vein anastomosis.
Two patients in this series required operative evacua-
tion of a hemothorax (one through the previous supracla-
vicular incision and one through a separate thoracic proce-
dure), and two required drainage of a wound hematoma or
control of a lymph leak, or both. These seven patients
ultimately recovered well, without further complications or
delays in recovery.
Of the 19 patients who underwent creation of an
adjunctive AVF at the time of the primary operation, spon-
taneous asymptomatic thrombosis occurred in 5 (26%)
within 12 weeks of operation (Table IV), and 15 (74%)
remained patent until elective ligation under local anesthe-
sia, which was performed 11.9  0.5 weeks after the
primary operation. Intraoperative venography was per-
formed in several cases at the time of AVF ligation to verify
the patency of subclavian vein reconstruction (Fig 2,M-P).
All anticoagulant and antithrombotic medications were
discontinued 12 weeks after the primary operation.
Inpatient physical therapy was initiated the day after
operation to maintain upper extremity range of motion.
Postoperative rehabilitation was then overseen by a physical
therapist dedicated to the management of TOS in conjunc-
tion with a physical therapist located near the patient.
Long-term rehabilitation was directed by a team physician
or athletic trainer with no restrictions placed on activity
after postoperative week 12. Data shown in Table IV
demonstrate that the median time interval between opera-
tion and the return to competitive athletic activity was 3.5
months (range, 2-10 months), with 16 patients (50%)
resuming participation in their sport by 3 months.
By annual office examinations or telephone interview,
the median duration of postoperative follow-up was 3.6
years (range, 0.5-10.0 years), with all patients continuing
to have unrestricted use of the upper extremity and excel-
lent long-term outcomes. Most of the individuals in this
series returned to a level of athletic performance at least
equivalent to that achieved before the development of
effort thrombosis, and many continued on to highly suc-
cessful athletic careers. Those who later completed their
participation in organized athletics continued to remain
active in sports and recreational activities, having chosen
alternative careers for reasons unrelated to upper extremity
venous symptoms or surgical treatment (eg, school gradu-
ation).
Overall duration of management. To further assess
factors that influenced the outcome of treatment, the over-
all duration of clinical management was determined for
each patient as measured from the onset of symptoms until
a full return to competitive athletic activity and compared
with four discrete intervals in the course of clinical care (Fig
3, A). No significant correlations were found between the
overall duration of management and the interval fromsymptoms to diagnosis (P  .16), the duration of surgical
hospitalization (P .26), or the interval from operation to
full return to athletic activity (P  .14). In contrast, the
Fig 3. Time-course of clinical management and return to athletic
activity. A, The bars on the graph illustrate the overall time-course
of clinical management for 32 competitive athletes with effort
thrombosis. Interval A represents the time from the onset of
symptoms to venographic diagnosis; interval B represents the time
from venographic diagnosis to operative treatment; interval C
represents the period of postoperative hospitalization; and interval
D represents the time from operation to a complete return to
athletic activity. The numbers in brackets indicate the total dura-
tion of management from the initial symptoms to a complete
return to athletic activity. B, Scatter plot shows the association
between the overall duration of management (the time from initial
symptoms to the complete return to competitive athletics) and the
time interval from diagnosis to operation. Data were compared
using the Pearson correlation test, with a two-tailed value of P 
.05 considered significant.overall duration of management was correlated with the
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correlation coefficient r  0.820; Fig 3, B).
To complement this assessment, a separate analysis of
outcomes was conducted for three distinct groups: (1) 20
patients treated initially at our institution or referred imme-
diately after initial treatment elsewhere; (2) seven patients
initially treated elsewhere and not immediately referred,
who had persistent symptoms on anticoagulation alone;
and (3) five patients initially treated elsewhere and not
immediately referred, who had documented subclavian re-
thrombosis. This revealed that patients with persistent
symptoms or rethrombosis after initial nonsurgical man-
agement also had significantly longer intervals between
symptoms and diagnosis, diagnosis to operation, and post-
operative stay, as well as overall duration of management,
compared with patients initially managed at our institution
or directly referred after initial diagnosis/intervention else-
where (Fig 4).
These observations reinforce the notion that prompt
referral for comprehensive surgical management is a prin-
cipal determinant of the overall time required to resume
unrestricted upper extremity activity. In contrast, it is in-
teresting to note that no significant association was found
between the interval from diagnosis to operation and the
interval from operation to full return to athletic activity
(P .85), and that the interval between operation and the
return to athletic activity was not significantly different
between patients with persistent symptoms or rethrombo-
sis after initial nonsurgical management and those initially
managed at our institution or directly referred after initial
diagnosis/intervention elsewhere (Fig 4, D). Thus, the
patients in this series were still able to return to competitive
athletics within a reasonable and consistent period of time
after operative treatment, even after multiple previous in-
terventions or prolonged delays in referral.
DISCUSSION
Effort thrombosis of the subclavian vein is often related
to vigorous overhead use of the arm in occupational or
recreational activities, and it is the most common vascular
disorder affecting the professional, collegiate, or high-
school athlete. Management of venous TOS is particularly
demanding in these individuals, because incomplete treat-
ment may prevent future participation in sports and be-
cause there are substantial pressures to achieve a rapid
return to previous levels of physical performance. Existing
information is, unfortunately, limited regarding the out-
comes of treatment for effort thrombosis in the competitive
athlete and consists largely of single case reports or small
components of clinical series.11,20-28 To our knowledge,
the present study therefore represents the largest collected
series of competitive athletes treated for venous TOS re-
ported to date.
Current pathophysiologic concepts indicate that effort
thrombosis can be considered an acute manifestation of a
chronic condition rather than a single traumatic event
(Supplemental Fig C, on-line only). This revised view has
had important implications for clinical management, withan emphasis on the central role of extrinsic compression,
the chronic fibrotic response to repetitive venous injury,
and the function of venous collaterals in forestalling symp-
toms. In this study we found the diagnostic sensitivity of
upper extremity venous DUS to be relatively low (71%),
probably reflecting technical difficulties in accurately imag-
ing the subclavian vein beneath the clavicle, confounding
effects of expanded collateral veins, and differences in tech-
nique across various laboratories. This observation empha-
sizes that negative DUS results cannot be taken to exclude
the diagnosis of effort thrombosis in the presence of clinical
suspicion.
Standard care for suspected effort thrombosis now
includes contrast venography for definitive diagnosis and
catheter-directed thrombolytic therapy.13,14 Balloon an-
gioplasty of the underlying subclavian vein stenosis is often
unsuccessful owing to extrinsic compression and dense
perivenous scar tissue, and immediate elastic recoil or reste-
nosis frequently occur. There is broad consensus that en-
doluminal stents should not be used in the initial manage-
ment of effort thrombosis because subclavian vein
compression frequently results in stent bending, frac-
ture, or rethrombosis, as illustrated by one patient in this
series.11,15-17
Thoracic outlet decompression is generally consid-
ered the definitive treatment for effort thrombosis, but
questions remain about the optimal timing and specific
surgical techniques for the management of venous
TOS.13,14 Although it appears safe to perform transaxillary
first rib resection immediately after thrombolysis or within
the same hospitalization,29 to minimize bleeding compli-
cations, we have previously favored a 1 to 3 week interval
between treatment with thrombolytic agents and paracla-
vicular decompression. This interval has notably declined
with the recent use of pharmacomechanical thrombec-
tomy, where the duration and amount of thrombolytic
agent is decreased.30,31
Some surgeons advocate medial claviculectomy or
transaxillary first rib resection for venous TOS (with or
without postoperative balloon angioplasty or placement of
stents),29,32-37 and others recommend an approach that
couples anterior thoracic outlet decompression (subcla-
vicular or paraclavicular) with direct subclavian vein recon-
struction.18,38-40 We believe the paraclavicular approach
is the most comprehensive and versatile of these options
because it allows improved surgical exposure, more thor-
ough anatomic decompression of the thoracic outlet,
complete resection of the first rib, and wide access to the
axillary, subclavian, jugular, and innominate veins. Para-
clavicular exposure also permits identification of ana-
tomic anomalies that might not be detected using alter-
native approaches, as illustrated by two patients in this
series with subclavian vein compression caused by a
prevenous phrenic nerve, and it does not require partial
claviculectomy, disruption of the sternoclavicular joint,
or partial sternotomy.
In the treatment of venous TOS we also favor circum-
ferential external venolysis and direct reconstruction for
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vian vein. Our experience indicates that venolysis alone is
sufficient to restore a widely patent vein in approximately
50% of patients, and the use of vein patch angioplasty or
interposition bypass avoids routine reliance on indirect
adjuncts, such as postoperative balloon angioplasty and
stent placement. Although Schneider et al36 reported ex-
cellent results with postoperative balloon angioplasty after
paraclavicular decompression, the larger series reported by
Molina et al40 supports the efficacy of direct venous
reconstruction. Despite the suggested utility of subcla-
vian vein stents after thoracic outlet decompression,35
indwelling stents in this position have a substantial rate of
rethrombosis and their long-term function in young active
patients is still unclear.
Our current approach includes the creation of a tem-
porary AVF in most patients with venous TOS. Although
initially intended to diminish venous thrombosis during the
first several months after operation,19 another advantage is
that a patent AVF can enhance the early detection of
postoperative venous complications and lead to prompt
treatment and satisfactory outcomes, as illustrated by three
patients in this series. Patients with a functioning AVF and
no evidence of arm swelling can therefore be expected to
have a widely patent axillary-subclavian vein system, subse-
quently avoiding the need for routine venography during
follow-up care. Indeed, one of the limitations of this and
other studies is the absence of long-term venographic follow-
up to assess the patency of subclavian vein reconstructions,
because DUS imaging is of limited value in follow-up
assessment and contrast imaging is not routinely performed
in the absence of venous symptoms. Long-term subclavian
vein patency will therefore need to be addressed with more
rigor in future investigations.
The management of venous TOS remains a particular
challenge in patients with longstanding symptoms,
chronic subclavian vein thrombosis, long segments of
axillary-subclavian vein obstruction, or multiple previous
interventions (including stent placement). It is important
to note that the operative strategies used in the present
series have allowed us to undertake treatment for a much
broader spectrum of patients than might be treated by
alternative approaches. For example, in the largest series
reported to date,Molina et al40 described 114 patients with
Fig 4. Graphs show the effects of initial management a
treatment. Patient outcomes were analyzed according
WashingtonUniversity/ Barnes-JewishHospital (WU/B
group II, initial management elsewhere with persistent s
elsewhere with documented subclavian vein rethrombos
onset of symptoms to venographic diagnosis.B, Interval
treatment.C, Interval C represents the period of postope
operation to a complete return to athletic activity. E, Int
the initial symptoms to a complete return to athletic activ
Statistical comparisons between groups weremade using
comparisons testing are indicated (NS, not significant).venous TOS, of which 17 presented more than 2 weeks
after the onset of effort thrombosis (Molina group II).
Despite a highly successful approach with frequent use of
subclavian vein patch angioplasty, these authors considered
70% of their group II patients to be inoperable because of
progressive fibrosis and persistent venous occlusion. In
contrast, many of the patients in the present series, as well as
our overall experience, appear to have met these same
criteria and yet underwent successful surgical management
by the strategies described here.
Finally, it is important to emphasize that optimal care
for patients with effort thrombosis is achieved by inter-
disciplinary team management, including specialists in
vascular or thoracic surgery, interventional radiology,
and physical therapy, and is ideally based on broad
experience with the management of all forms of TOS. In
the care of the competitive athlete with venous TOS,
successful outcomes are also dependent on the close
involvement of specialists in sports medicine and ortho-
pedics, team physicians, and individual athletic trainers,
particularly to help promote appropriate postoperative
follow-up, detection and management of potential com-
plications, and a smooth transition to the resumption of
athletic activities.
We are grateful to the referring physicians, interven-
tional radiologists, team physicians, and athletic trainers
who allowed us to participate in the care of the patients
described in this article. We are indebted to Terri Moriarty,
LPN, for expert surgical assistance, and to Verdella F.
Brink, for helping care for all of our patients with thoracic
outlet syndrome.
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